malignant lymphoma
Showing 1 - 23 of 23
COVID-19 Infection in Malignant Lymphomas Participating in
Completed
- Malignant Lymphoma
- +2 more
- No intervention
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-Sen University Cancer Ce
Apr 22, 2023
Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)
Not yet recruiting
- Malignant Lymphoma
- Multiple Myeloma
- Pentaisomaltose
- (no location specified)
Jan 5, 2023
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Patients With Solid Tumors and Malignant Lymphoma
Completed
- Anemia, Iron Deficiency
- +2 more
- non-interventional retrospective epidemiological observational study
-
Kaiserslautern, GermanyStudienzentrum Prof. Dr. med. Hartmut Link, Facharzt für Innere
Feb 14, 2022
COVID-19 After Autologous Hematopoietic Stem Cell
Completed
- Covid19
- +4 more
- Autologous stem cell transplantation
-
Uppsala, SwedenUppsala Universitet
Feb 7, 2022
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)
Withdrawn
- Acute Myeloid Leukemia
- +7 more
- MDG1021 dose 1
- +3 more
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Sep 30, 2021
Radiotherapy Side Effect, NSCLC, Esophageal Cancer Trial in Groningen (CPAP)
Recruiting
- Radiotherapy Side Effect
- +3 more
- CPAP
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 22, 2021
Lean Body Mass and Side Effects in Patients With Lymphoma
Recruiting
- Malignant Lymphoma
-
Copenhagen, Frederiksberg, Denmark
- +1 more
Jan 4, 2021
Malignant Lymphoma Trial in Tianjin (Toripalimab)
Completed
- Malignant Lymphoma
- Toripalimab
-
Tianjin, Tianjin, ChinaBlood Diseases Hospital, Chinese Academy of Medical Sciences
Sep 28, 2020
Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT
Completed
- Malignant Lymphoma
- +3 more
- (no location specified)
Jul 8, 2020
Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Rifampin)
Completed
- Hematologic Malignancy
- Malignant Lymphoma
-
Sarasota, Florida
- +2 more
Nov 14, 2019
Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Ketoconazole)
Completed
- Hematologic Malignancy
- Malignant Lymphoma
-
Sarasota, Florida
- +2 more
Nov 14, 2019
Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/
Completed
- Acute Myeloid Leukemia
- +10 more
- fludarabine/busulfan
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago Medical Center
Oct 9, 2018
Solid Tumor, Malignant Lymphoma, Tumor Trial in United States (ARQ 092)
Completed
- Solid Tumor
- +2 more
- ARQ 092
-
Birmingham, Alabama
- +6 more
Oct 19, 2017
Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem
Completed
- Acute Myelogenous Leukemia
- +8 more
- Fludarabine
- +3 more
-
Chicago, IllinoisThe University of Chicago
Oct 7, 2016
Advanced Solid Malignancies, Malignant Lymphoma Trial in Chuo-ku, Manchester, Surrey (AZD1208)
Completed
- Advanced Solid Malignancies
- Malignant Lymphoma
-
Chuo-ku, Japan
- +2 more
Oct 6, 2015
Malignant Lymphoma Trial in Worldwide (r-metHuSCF and Filgrastim, Chemotherapy plus Filgrastim)
Terminated
- Malignant Lymphoma
- r-metHuSCF and Filgrastim
- Chemotherapy plus Filgrastim
-
Aalborg, Denmark
- +7 more
Jun 24, 2015
Malignant Lymphoma Trial in Beijing (Mitoxantrone Hydrochloride Liposome)
Unknown status
- Malignant Lymphoma
- Mitoxantrone Hydrochloride Liposome
-
Beijing, ChinaCancer Hospital ,Chinese Academy of Mddical Sciences
May 4, 2014
Hematological Diseases, Hematological Malignancies, Blood Diseases Trial in Herlev (Bismuth tablets, Placebo tablets)
Completed
- Hematological Diseases
- +5 more
- Bismuth tablets
- Placebo tablets
-
Herlev, DenmarkDepartment of Haematology L, Herlev Hospital, Herlev Ringvej 75
Sep 9, 2013
Whole-body Magnetic Resonance Imaging for Staging Malignant
Completed
- Malignant Lymphoma
- +2 more
-
Amsterdam, Noord-Holland, Netherlands
- +2 more
Jul 2, 2013
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma
Completed
- Malignant Lymphoma
- P13K-AKT Pathway Deregulation
- p-AKT immunohistochemical staining
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 7, 2013